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In order to improve the results of treatment of patients with multi-resistant pulmonary tuberculosis with the use of surgical 
methods, the effectiveness estimation of conservative treatment of 176 patients with this form of tuberculosis according to cohort 
analysis data in two districts of Kyiv were done.
In the list were included following parameters: type of the tuberculosis, its clinical-radiological form and the prevalence of 
the process, the results of conservative treatment in patients who completely finished the course of anti-TB chemotherapy and the 
results of conservative treatment of 81 patients who had indications for surgical treatment but had not been operated. Processing of 
the materials of the study was carried out with the use of licensed software products included in the Microsoft Office Professional 
2007 package. The predicted results of treatment were calculated on the condition of surgical intervention.
Out of the total sample of patients, 31.3 % of the patients completed treatment. Mortality was 16.5 %, transferred to palliative 
care 11.9 %. More than one in three patients (35.2 %) stopped treatment at different times from the start. 
According to the clinic of thoracic surgery SU “National Institute of Phthisiology and Pulmonology named after 
F. G. Yanovsky NAMS of Ukraine“, the overall effectiveness of treatment for patients with limited multidrug-resistant tuberculosis 
with the use of surgical intervention is about 95 % in the absence of mortality. We have modelled the potential results of treatment 
of the selected cohort in case of the surgical stage is fully and timely applied in a complex of therapeutic treatment. If all 81 patients 
with indications for surgical treatment used that way, then, with the above efficiency, a complete cure could be predicted in 77 pa-
tients (44.5 % of the total number of observations), which in turn would allow predicting the achievement completion of treatment at 
64.2 % with complete cure for 60.6 % of patients.
Thus, it is established that the positive result of surgical treatment in the general complex of treatment measures in patients 
with multidrug-resistant pulmonary tuberculosis is able to improve the results of treatment of this contingent more than twice, re-
duce the mortality almost by three times, reduce the need for repeated courses of treatment from 7.4 % to 1.7 %, as well as to reduce 
the epidemiological reservoir of infection due to a significant decrease in the number of patients with failure to treat tuberculosis, 
interrupted and palliative treatment.
Keywords: tuberculosis, lungs, multidrug resistance, surgical treatment.
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1. Introduction
In the treatment of pulmonary tuberculosis, which is accompanied by irreversible morpho-
logical changes in the pulmonary tissue [1, 2], surgical methods are a priority [3]. At the same 
time, chemoresistance of mycobacterium tuberculosis (MBT) is increasingly inducing the expand-
ed use of surgical methods for treating patients in this category [4, 5], since conservative methods 
for treating patients with a common destructive multidrug-resistant pulmonary tuberculosis do 
not meet current requirements [6] and provide complete cure, on average, only in 8.0 % of cases 
[7]; the lethal outflow during the course of the main course of treatment for caseous pneumonia 
is 64.3–76.4 % of cases [8, 9]. According to the available data [10], despite significant drugs and 
various methods of chemotherapy, treatment of multiple/polysaccharide destructive tuberculosis is 
unsatisfactory: after more than 3 months of therapy, the smear conversion was observed in only a 
quarter of patients, with only 14.3 % of them it corresponded to the improvement of clinical and 
radiological data [11, 12].
Drug resistance is, at present, the main challenge in global control of tuberculosis in connec-
tion with the small selection of treatment methods [13, 14]. In general, surgery has proven effective 
in treating patients with multi-resistant tuberculosis. Accordingly, a combined therapeutic and sur-
gical approach is increasingly used to treat these patients [15, 16].
At the same time, the contingents of patients who were treated with the use of surgical 
methods are significantly different [17]. Accordingly, there are significant differences in the as-
sessment of the effectiveness of the use of surgery in the complex treatment of patients with pul-
monary tuberculosis in general and chemo-resistant in particular [18]. There was accumulated 
essential experience of surgical treatment of patients with common and complicated tuberculosis 
[19]. The feasibility and effectiveness of treatment of local forms of pulmonary tuberculosis is 
not well understood [20]. Argumentative issue remains the expediency of surgical treatment 
of patients with significant X-ray manifestations of the tuberculosis process in the absence of 
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destruction, in the absence of bacterial separation, or its termination on the background of con-
servative treatment. The need for solving these issues has been recognized as one of the priority 
tasks of phthisiology and, in particular, phthisiosurgery, at the level of the World Health Orga-
nization [21, 22].
2. Aim of the research
Estimation of reserves for improvement of the treatment of patients with limited forms of 
multi-resistant pulmonary tuberculosis in the application of surgical methods.
3. Materials and methods
An evaluation of the effectiveness of treatment for patients with multidrug-resistant pul-
monary tuberculosis (MDR-PTB) was performed based on cohort analysis data in two districts of 
Kyiv. The study included all 176 MDR-PTB patients and those with advanced resistant tuberculosis 
(ARTB) that was registered in the specified areas during 2013–2014 (general population). Surgical 
treatment in these patients was not performed.
In the list were included following parameters: the type of TB, its clinical-X-ray form, the 
prevalence of the tuberculous process, the general results of conservative treatment in patients 
who had completely completed the course of anti-TB chemotherapy, the results of conservative 
treatment in patients who had indications for surgical treatment separately and in relation to overall 
results in the general population.
Based on the allocation of contingent with indications for surgical treatment, a separate 
analysis of treatment outcomes in this subgroup, their impact on overall outcomes, and, based on 
the known efficacy of surgical treatment, a prediction of possible efficacy with adequate surgical 
application in the overall set of therapeutic measures was calculated.
Collection, storage and mathematical processing of the materials of the study were con-
ducted using the licensed software products included in the Microsoft Office Professional 2007 
package, the license Russian Academic OPEN No Level 43437596. The studies were performed 
with the state budget.
4. Results
All patients had chemoresistance, which was confirmed bacteriologically. Distribution by 
types of chemoresistance is presented in Table 1.
Table 1
Distribution of the examined patients by the type of resistance to anti-TB drugs






As can be seen from Table 1, three-quarters of patients had multi-resistance, one quarter – 
advanced resistance.
The distribution of the examined patients depending on the type of the disease is presented 
in Table 2.
As follows from Table 2, according to the types of tuberculosis patients were divided into 
approximately equal groups: each of the types had about a quarter of the total. Somewhat predomi-
nantly patients with a failure of treatment were 27.3 %, slightly less was the number of patients with 
the case of “treatment after a pause” 19.9 %.
Distribution of patients according to clinical and radiological forms is presented in Table 3.
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Distribution of surveyed patients by type of tuberculosis
Type of pulmonary tuberculosis
Number of patients
absolute %
First time diagnosed tuberculosis 46 26.1
Tuberculosis recurrence 47 26.7
Failure of treatment 48 27.3
Treatment after a pause 35 19.9
Total 176 100.0
Table 3







Caseous pneumonia 1 0.6
Disseminated 27 15.3
Total 176 100.0
As can be seen from Table 3, infiltrative tuberculosis with a disintegration or without dis-
integration in 56.3 % of cases and fibro-cavernous tuberculosis in 26.7 % of cases were the most 
frequently observed. We consider it advisable to note that only 2 patients with tuberculomas were 
observed 1.1 %, which, in our opinion, is due to the highest surgical activity in relation to the men-
tioned clinical and radiological forms of tuberculosis.
In the prevalence of tuberculosis, unilateral lesions prevailing at 58.5 %; the process in the 
lobe was observed in 45.5 % of patients (Table 4).
Table 4
Distribution of surveyed patients according to the prevalence of tuberculous process
Prevalence of tuberculous process
Number of patients
absolute  %
Unilateral lesions 103 58.5
Bilateral lesions 73 41.5
Process in one lobe 80 45.5
More than one lobe 96 54.5
In general, out of the number of patients examined, indications for surgical treatment had, 
at a minimum (patients not taken into account in bilateral processes, where the decision on the 
question of surgical treatment should be solved individually) 81 patients (46.3 %). The distribu-
tion of the examined patients who had indications for surgical treatment, as needed in different 
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resection volumes, was as follows: sublobular resection or lobectomy was shown in 58 patients 
(71.6 %), combined resction or pneumonectomy - in 23 patients (28.4 %). We remind that for vari-
ous non-objective reasons, surgery was not used.
The general results of the treatment of the examined patients are presented in Fig. 1. It 
should be noted that bacterial secretion, as a separate criterion, was not carried out, since bacterial 
secretion, negative clinical and radiological dynamics, and complications of the tuberculous pro-
cess were exhibited as a failure. As a result, 31.3 % of the patients completed the treatment among 
the total sample of patients who were taken into account in two districts of Kyiv. Mortality was 
16.5 %, transferred to palliative care 11.9 %. More than one in three patients (35.2 %) stopped treat-
ment at different times from the start. 
Fig. 1. Indicators of cohort analysis of the results of conservative treatment in patients with 
multidrug-resistant pulmonary tuberculosis
Among the patients who had indications for surgical treatment, the results of the treatment 
were significantly worse (Fig. 2) by the overwhelming majority of the comparison criteria. The 
reduction in the number of patients with a pause in treatment is most likely due to an increase in 
failure rates and mortality rates.
Fig. 2. Indicators of cohort analysis of the results of conservative treatment in patients with 
multidrug-resistant pulmonary tuberculosis, which had indications for surgical treatment
5. Discussion
Proceeding from the fact that according to our clinic, the overall efficacy of treatment for 
patients with limited multidrug-resistant tuberculosis with surgical intervention is about 95 % in 
the absence of mortality [3], we simulated the potential outcomes of treatment of the selected con-
tingent in case of the full and timely use of the surgical stage in a complex of medical measures. 
If all 81 patients with indications for surgical treatment used it, then, with the above efficiency, a 
complete cure could be predicted in 77 patients (44.5 % of the total number of observations), which 
in turn would allow predicting the achievement completion of treatment at 64.2 % with complete 
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Fig. 3. Estimated (projected) indicators of cohort analysis of treatment outcomes in patients with 
multi-resistant pulmonary tuberculosis, provided that adequate surgical treatment is used in the 
overall set of therapeutic measures
6. Conclusions
1. Adequate use of surgical treatment in the general complex of therapeutic measures in pa-
tients with multidrug-resistant pulmonary tuberculosis can provide improved treatment results for 
this contingent more than twice, reduce lethality almost three times, reduce the need for repeated 
courses of treatment from 7.4 % to 1.7 %.
2. The application of surgical treatment in the general complex of therapeutic measures in 
patients with multidrug-resistant pulmonary tuberculosis will contribute to the reduction of the 
epidemiological reservoir of infection due to a significant decrease in the number of patients with 
failure to treat tuberculosis, interrupted and palliative care.
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